Form 4 · Filed Jul 1, 2026, 12:01 AM UTC
EW/Edwards Lifesciences Corp
Lippis Daniel J. — CVP, TAVR
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | M | other | 619 | $73 | $44,989 | 41,030 |
| Jun 30, 2026 | S | sell | 619 | $91 | $56,577 | 40,411 |
| Jun 30, 2026 | M | other | 619 | — | — | 5,571 |
Source: SEC EDGAR raw filing ↗ · Accession 0001225208-26-006263